191 related articles for article (PubMed ID: 287029)
21. Globin synthesis and erythroid differentiation in a Friend cell variant deficient in heme synthesis.
Rutherford TR; Harrison PR
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5660-4. PubMed ID: 293668
[TBL] [Abstract][Full Text] [Related]
22. Role of activator protein-1 and methylation function in 12-O-tetradecanoylphorbol-13-acetate--mediated inhibition of differentiation of Friend erythroleukemia cells.
Bertrand O; Giroldi L; Nakazawa H; Sergeant A; Yamasaki H
Mol Carcinog; 1992; 6(3):214-20. PubMed ID: 1445621
[TBL] [Abstract][Full Text] [Related]
23. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.
Lotem J; Sachs L
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5158-62. PubMed ID: 291929
[TBL] [Abstract][Full Text] [Related]
24. Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.
Melloni E; Pontremoli S; Damiani G; Viotti P; Weich N; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3835-9. PubMed ID: 3163801
[TBL] [Abstract][Full Text] [Related]
25. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells.
Yamasaki H; Weinstein IB; Fibach E; Rifkind RA; Marks PA
Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635
[No Abstract] [Full Text] [Related]
26. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
Fibach E; Reuben RC; Rifkind RA; Marks PA
Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of transferring binding and iron uptake of hematopoietic cell lines by phorbol esters.
Pelicci PG; Testa U; Thomopoulos P; Tabilio A; Vainchenker W; Titeux M; Gourdin MF; Rochant H
Leuk Res; 1984; 8(4):597-609. PubMed ID: 6088899
[TBL] [Abstract][Full Text] [Related]
28. Partial purification and characterization of phorbol ester-regulated translational inhibitor(s) in human HL-60 leukemic cells.
Konno S; Borelli TJ; Wu JM
J Biol Chem; 1986 Apr; 261(11):5010-7. PubMed ID: 3457011
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of functional and morphological differentiation of cultured mouse myeloid leukemia cells by tumor promoters.
Kasukabe T; Honma Y; Hozumi M
Gan; 1979 Feb; 70(1):119-23. PubMed ID: 286666
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells.
Nudel U; Salmon JE; Terada M; Bank A; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1100-4. PubMed ID: 265555
[TBL] [Abstract][Full Text] [Related]
32. Studies on the mechanism of action of hexamethylene bisacetamide, a potent inducer of erythroleukemic differentiation.
Reuben RC
Biochim Biophys Acta; 1979 Dec; 588(3):310-21. PubMed ID: 292456
[TBL] [Abstract][Full Text] [Related]
33. Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division.
Marks PA; Chen Z; Banks J; Rifkind RA
Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2281-4. PubMed ID: 6572977
[TBL] [Abstract][Full Text] [Related]
34. Phorbol ester induced prostaglandin synthesis and [3H]-TPA metabolism by TPA-sensitive and TPA-resistant Friend erythroleukemia cells.
Yamasaki H; Mufson RA; Weinstein IB
Biochem Biophys Res Commun; 1979 Aug; 89(3):1018-25. PubMed ID: 290357
[No Abstract] [Full Text] [Related]
35. Sequential activation of genes for heme pathway enzymes during erythroid differentiation of mouse Friend virus-transformed erythroleukemia cells.
Fujita H; Yamamoto M; Yamagami T; Hayashi N; Bishop TR; De Verneuil H; Yoshinaga T; Shibahara S; Morimoto R; Sassa S
Biochim Biophys Acta; 1991 Nov; 1090(3):311-6. PubMed ID: 1954253
[TBL] [Abstract][Full Text] [Related]
36. Induced differentiation of murine erythroleukemia cells: cellular and molecular mechanisms.
Rifkind RA; Sheffery M; Marks PA
Adv Cancer Res; 1984; 42():149-66. PubMed ID: 6395654
[TBL] [Abstract][Full Text] [Related]
37. Modulation of globin gene expression by a tumor promoter during induced differentiation of Friend erythroleukemic cells.
Shaul Y; Ginzburg I; Aviv H
Eur J Biochem; 1981 Mar; 114(3):591-5. PubMed ID: 6113141
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative regulation of specific gene expression by the tumor promoter TPA in human erythroleukemic K562 cells.
Siebert PD; Fukuda M
Prog Clin Biol Res; 1985; 191():233-48. PubMed ID: 3863149
[TBL] [Abstract][Full Text] [Related]
39. Proliferation is required for induction of terminal differentiation of Friend erythroleukemia cells.
Spriggs LL; Hill SM; Jeter JR
Biochem Cell Biol; 1992 Jul; 70(7):555-64. PubMed ID: 1449723
[TBL] [Abstract][Full Text] [Related]
40. Human erythroleukemia cell line (HEL) undergoes a drastic macrophage-like shift with TPA.
Papayannopoulou T; Nakamoto B; Yokochi T; Chait A; Kannagi R
Blood; 1983 Oct; 62(4):832-45. PubMed ID: 6309287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
